| Q36049975 | A PMLRARalpha transgene initiates murine acute promyelocytic leukemia |
| Q43112084 | A case of a novel PML/RARA short fusion transcript with truncated transcription variant 2 of the RARA gene. |
| Q24532092 | A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein |
| Q24532134 | A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein |
| Q41065219 | A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARalpha fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias |
| Q90393590 | Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene |
| Q36771988 | Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice |
| Q28574947 | Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells |
| Q89552752 | Advances in Pediatric Acute Promyelocytic Leukemia |
| Q48131869 | Breakpoint clusters of the PML gene in acute promyelocytic leukemia: Primary structure of the reciprocal products of the PML‐RARA gene in a patient with t(15;17) |
| Q33854193 | CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment |
| Q24318605 | Cellular localization, expression, and structure of the nuclear dot protein 52 |
| Q54997337 | Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia. |
| Q40458874 | Contribution of immunophenotypic and genotypic analyses to the diagnosis of acute leukemia |
| Q42528863 | Cryptic insertion of PML-RARA into the 3p25 locus in an acute promyelocytic leukemia with t(3;17)(p25;q21) |
| Q36761829 | Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea |
| Q55008428 | Detection of PML/retinoic acid receptor a gene rearrangements by polymerase chain reaction using genomic DNA in patients with acute promyelocytic leukemia. |
| Q35225262 | Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia |
| Q72607342 | Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia |
| Q43706167 | Effect of additional chromosomal abnormalities in acute promyelocytic leukemia treated with all-trans-retinoic acid: a report of 17 patients |
| Q35560268 | Epidemiology and treatment of acute promyelocytic leukemia in latin america |
| Q59351847 | Expression of Human Cytomegalovirus IE1 Leads to Accumulation of Mono-SUMOylated PML That Is Protected from Degradation by Herpes Simplex Virus 1 ICP0 |
| Q37031781 | Expression pattern of the RAR alpha-PML fusion gene in acute promyelocytic leukemia |
| Q42078133 | FISH detection of PML-RARA fusion in ins(15;17) acute promyelocytic leukaemia depends on probe size |
| Q24604850 | Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia |
| Q61808046 | Functional impairment of the HIPK2 small ubiquitin-like modifier (SUMO)-interacting motif in acute myeloid leukemia |
| Q24564693 | Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia |
| Q53014851 | Heterogeneity of V52 TCR 8 Gene Rearrangements in Acute Myeloid Leukemia |
| Q35782722 | Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. |
| Q37032428 | Immunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomas |
| Q27852289 | Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia |
| Q54937608 | Molecular heterogeneity of the PML gene rearrangement in acute promyelocytic leukemia: prevalence and clinical significance. |
| Q35190696 | Monitoring PML-RARalpha in acute promyelocytic leukemia |
| Q54268356 | Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors. |
| Q26767396 | Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways |
| Q34996318 | New advances in the treatment of acute promyelocytic leukemia |
| Q52328823 | New chimeric RNAs in acute myeloid leukemia. |
| Q40023123 | Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling. |
| Q24563942 | PLZF-RAR alpha fusion proteins generated from the variant t(11;17)(q23;q21) translocation in acute promyelocytic leukemia inhibit ligand-dependent transactivation of wild-type retinoic acid receptors |
| Q41792379 | PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53. |
| Q24324168 | PML, a growth suppressor disrupted in acute promyelocytic leukemia |
| Q34057370 | PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR |
| Q35914635 | Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination |
| Q34728496 | Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia |
| Q39822314 | Quantitative detection of PML-RARalpha fusion transcript by real-time PCR with a single primer pair. |
| Q34004662 | Retinoic acid receptor alpha1 variants, RARalpha1DeltaB and RARalpha1DeltaBC, define a new class of nuclear receptor isoforms |
| Q28367104 | Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation |
| Q39016075 | Sp100 isoform-specific regulation of human adenovirus 5 gene expression |
| Q40967354 | Specific destruction of kinetochore protein CENP-C and disruption of cell division by herpes simplex virus immediate-early protein Vmw110. |
| Q35612561 | Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis |
| Q71846545 | The PML gene is linked to a megabase-scale insertion/deletion restriction fragment length polymorphism |
| Q42022579 | The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription |
| Q33783492 | The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms |
| Q51082277 | The impact of Tegillarca granosa extract haishengsu on HL-60 cell. |
| Q24324766 | The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein |
| Q58544569 | Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy |
| Q33642090 | Transforming potential of the adenovirus type 5 E4orf3 protein |
| Q38026794 | Tumor suppressive pathways in the control of neurogenesis. |
| Q27851641 | Use of whole-genome sequencing to diagnose a cryptic fusion oncogene |
| Q34064907 | Variant-type PML-RAR(alpha) fusion transcript in acute promyelocytic leukemia: use of a cryptic coding sequence from intron 2 of the RAR(alpha) gene and identification of a new clinical subtype resistant to retinoic acid therapy |
| Q35869329 | t(15;17) Reverse transcription-polymerase chain reaction with alternative splicing |